Related Experiment Video
Updated: May 4, 2026
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Radiofrequency ablation in metastatic melanoma
Arridh Shashank1, Mena Shehata, David L Morris
1Melanoma Institute Australia, North Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Radiofrequency ablation (RFA) offers a minimally invasive option for metastatic melanoma in the lung and liver. This study reviews RFA principles and outcomes for melanoma metastases, presenting new patient data.
Area of Science:
- Oncology
- Interventional Radiology
Background:
- Radiofrequency ablation (RFA) is established for primary liver cancers.
- Limited data exist on RFA for melanoma metastases in lung, liver, or adrenal glands.
Purpose of the Study:
- To explore RFA principles, safety, and efficacy for metastatic melanoma.
- To review existing literature and present new case series data.
Main Methods:
- Review of published RFA data for melanoma metastases.
- Presentation of a small series of patients with liver and lung metastases treated with RFA.
Main Results:
- RFA shows promise as a minimally invasive treatment for melanoma metastases.
- Further data are needed to fully establish RFA's role in managing melanoma spread.
Conclusions:
- Radiofrequency ablation is a viable, minimally invasive therapeutic option for select patients with metastatic melanoma.
- Continued research and data collection are essential to optimize RFA application in melanoma management.
More Related Videos
04:22Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019